• Search History (Register)
  • MeSH Browser
Sort by Relevance
Search Results [83 Hits] Selected Records [0 Hits] [Clear]
Year Source Title
2024 National Institute for Health and Care Excellence (NICE) Linzagolix for treating moderate to severe symptoms of uterine fibroids. NICE technology appraisal guidance 996
2024 Haute Autorite de sante (HAS) [Evaluation of high-intensity focused ultrasound (HIFU) for the treatment of symptomatic uterine fibroids]
2024 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Linzagolix (uterine fibroids) – Benefit assessment according to §35a Social Code Book V]
2023 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [UAE and MRgFUS versus myoma enucleation - Evidence report for the S3 guideline on diagnosis and treatment of benign diseases of the uterus]
2022 NIHR Health Technology Assessment programme Uterine artery embolisation versus myomectomy for premenopausal women with uterine fibroids wishing to avoid hysterectomy: the FEMME RCT
2022 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Radiofrequency ablation for treatment of symptomatic uterine myomas]
2022 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Relugolix/estradiol/norethisterone (uterine fibroid) - Benefit assessment according to §35a Social Code Book V]
2022 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Transcervical radiofrequency ablation with intrauterine ultrasound guidance for uterine fibroids]
2022 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Relugolix/estradiol/norethisterone (uterine fibroid) - Benefit assessment according to §35a Social Code Book V]
2022 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Transcervical radiofrequency ablation with intrauterine ultrasound guidance for uterine fibroids - Addendum to commission H21-14]
2022 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Transcervical radiofrequency ablation with intrauterine ultrasound guidance for uterine fibroids - Second addendum to commission H21-14]
2022 National Institute for Health and Care Excellence (NICE) Relugolix–estradiol–norethisterone acetate for treating moderate to severe symptoms of uterine fibroids. NICE technology appraisal guidance 832
2021 Norwegian Institute of Public Health (NIPH) [Hysterectomy for heavy menstrual bleeding: rapid health technology assessment]
2021 National Institute for Health and Care Excellence (NICE) Laparoscopic removal of uterine fibroids with power morcellation. NICE interventional procedures guidance 703
2021 National Institute for Health and Care Excellence (NICE) Hysteroscopic mechanical tissue removal (hysteroscopic morcellation) for uterine fibroids. NICE interventional procedures guidance 704
2021 National Institute for Health and Care Excellence (NICE) Transcervical ultrasound-guided radiofrequency ablation for symptomatic uterine fibroids. NICE interventional procedures guidance 689
2020 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Intrauterine ultrasound-guided transcervical radiofrequency ablation
2019 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ultrasound-guided high-intensity focused ultrasound for uterine fibroids - 2nd addendum to commission H16-02B]
2019 National Institute for Health and Care Excellence (NICE) Ultrasound-guided high-intensity transcutaneous focused ultrasound for symptomatic uterine fibroids. NICE interventional procedures guidance 657
2017 HAYES, Inc. Laparoscopic electromechanical morcellation of uterine fibroids during myomectomy orhysterectomy
2017 HAYES, Inc. Comparative effectiveness review of robotically assisted hysterectomy
2017 Institute for Clinical Effectiveness and Health Policy (IECS) [Ulipristal in uterine myomatosis]
2017 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ultrasound-guided high-intensity focused ultrasound for uterine fibroids: Assessment according to §137h Social Code Book V]
2017 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Magnetic resonance imaging-guided high-intensity focused ultrasound therapy for uterine myoma (Addendum to Commissions E14-04 and E14-05)]
2017 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Magnetic resonance imaging-guided high-intensity focused ultrasound therapy for uterine myoma: (2. Addendum to Commissions E14-04 and E14-05)]
2017 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ultrasound-guided high-intensity focused ultrasound for uterine fibroids - Addendum to commission H16-02B]
2017 Agency for Healthcare Research and Quality (AHRQ) Management of uterine fibroids
2016 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Ulipristal acetate (Esmya®)
2016 HAYES, Inc. Magnetic resonance-guided focused ultrasound therapy (ExAblate 2000; InSightec Ltd.) for ablation of uterine fibroids
2016 HAYES, Inc. Hysteroscopic morcellation for treatment of uterine submucosal fibroids and endometrial polyps
2016 HAYES, Inc. Laparoscopic radiofrequency volumetric thermal ablation (Acessa System; Halt Medical Inc.) for treatment of uterine fibroids
2015 Health Quality Ontario (HQO) Magnetic Resonance–Guided High-Intensity Focused Ultrasound (MRgHIFU) Treatment of Symptomatic Uterine Fibroids: An Evidence-Based Analysis
2015 Health Quality Ontario (HQO) Magnetic Resonance-Guided High-Intensity Focused Ultrasound (MRgHIFU) for Treatment of Symptomatic Uterine Fibroids: An Economic Analysis
2015 Health Quality Ontario (HQO) Magnetic Resonance–Guided High-Intensity Focused Ultrasound (MRgHIFU) for Treatment of Symptomatic Uterine Fibroids: OHTAC Recommendation
2015 Scottish Health Technologies Group (SHTG) Magnetic resonance guided focused ultrasound surgery (MRgFUS) for the treatment of uterine fibroids
2015 NIHR Horizon Scanning Centre (NIHR HSC) Sonata™ System for the removal of uterine fibroids
2014 HAYES, Inc. Robotically assisted hysterectomy
2014 HAYES, Inc. Magnetic Resonance-guided Focused Ultrasound (MRgFUS) therapy (ExAblate; InSightec Ltd.) for ablation of uterine fibroids
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Ulipristal Acetate (Fibristal - Actavis Specialty Pharmaceuticals Co.) indication: uterine fibroids
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Pharmacoeconomic review report. Ulipristal Acetate (Fibristal - Actavis Specialty Pharmaceuticals Co.) indication: uterine fibroids
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Clinical review report. Ulipristal Acetate (Fibristal - Actavis Specialty Pharmaceuticals Co.) indication: uterine fibroids
2014 HAYES, Inc. Laparoscopic radiofrequency volumetric thermal ablation (Acessa System; Halt Medical Inc.) for treatment of uterine fibroids
2014 HAYES, Inc. Hysteroscopic morcellation (Truclear Morcellator System; Smith & Nephew Inc.) for treatment of uterine submucosal fibroids and endometrial polyps
2014 HAYES, Inc. Laparoscopic electromechanical morcellation of uterine fibroids during myomectomy or hysterectomy
2014 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Magnetic resonance imaging-guided high-intensity focused ultrasound therapy for uterine fibroids]
2014 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Magnetic resonance imaging-guided high-intensity focused ultrasound therapy for uterine fibroids]
2013 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Ulipristal acetate (Esmya®)
2013 HAYES, Inc. Single-Incision Laparoscopic Surgery (SILS) for hysterectomy for benign disease
2013 Malaysian Health Technology Assessment (MaHTAS) HAIFU® Model- Jc focused ultrasound tumor therapeutic system - an update
2012 HAYES, Inc. Hysteroscopic morcellation (Truclear Morcellator System; Smith & Nephew Inc.) for treatment of uterine submucosal fibroids and endometrial polyps
2012 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Radiofrequency ablation of tumors of the urogenital tract (renal cell carcinoma, prostate cancer, uterine leiomyoma)]
2012 Secretaria de Ciencia, Tecnologia e Insumos Estrategicos, Departamento de Ciencia e Tecnologia (DECIT-CGATS ) [Uterine artery embolization in patients aiming to preserve the uterus]
2012 Andalusian Health Technology Assessment Area (AETSA) [Magnetic resonance guided focused ultrasound for uterine myomas ablation]
2011 Finnish Office for Health Care Technology Assessment (Finohta) [Uterine artery embolisation – an alternative treatment for symptomatic uterine fibroids]
2011 National Institute for Health and Care Excellence (NICE) Magnetic resonance image-guided transcutaneous focused ultrasound for uterine fibroids. NICE interventional procedures guidance 413
2010 HAYES, Inc. Robotically assisted hysterectomy
2010 National Institute for Health and Care Excellence (NICE) Uterine artery embolisation for fibroids. NICE interventional procedures guidance 367
2009 HAYES, Inc. Uterine artery embolization
2008 NIHR Health Technology Assessment programme Treatment for fibroids: Uterine Artery Embolisation (UAE) or hysterectomy (HOPEFUL) - Primary Research (e.g. trial)
2008 NIHR Health Technology Assessment programme A multi-centre retrospective cohort study comparing the efficacy, safety and cost-effectiveness of hysterectomy and uterine artery embolisation for the treatment of symptomatic uterine fibroids. The HOPEFUL study
2008 Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Efficacy, safety of high intensity focused ultrasound (HIFU-ExAblate)]
2008 Adelaide Health Technology Assessment (AHTA) MRI-guided high intensity ultrasound for the non-invasive treatment of uterine fibroids
2007 Agency for Healthcare Research and Quality (AHRQ) Management of uterine fibroids: an update of the evidence
2007 Adelaide Health Technology Assessment (AHTA) MRI guided high intensity focused ultrasound for the non-invasive treatment of symptomatic uterine fibroids
2007 HAYES, Inc. ExAblate 2000 system (InSightec Ltd.) for ablation of uterine fibroids
2006 Institute for Clinical Effectiveness and Health Policy (IECS) Uterine artery embolization for the management of uterine fibroids
2006 Adelaide Health Technology Assessment (AHTA) Uterine artery embolisation for the treatment of symptomatic uterine fibroids
2005 Canadian Coordinating Office for Health Technology Assessment (CCOHTA) MRI-guided focused ultrasound for treatment of uterine fibroids
2005 Blue Cross Blue Shield Association (BCBS) Magnetic resonance-guided focused ultrasound therapy for symptomatic uterine fibroids
2005 HAYES, Inc. Uterine artery embolization for treatment of fibroids
2005 Secretaria de Ciencia, Tecnologia e Insumos Estrategicos, Departamento de Ciencia e Tecnologia (DECIT-CGATS ) [Embolization in the treatment of uterine myoma]
2004 NIHR Health Technology Assessment programme Evaluation of abnormal uterine bleeding: comparison of three outpatient procedures within cohorts defined by age and menopausal status
2003 Institute for Clinical Systems Improvement (ICSI) Uterine artery embolization for uterine fibroids
2003 Wessex Institute for Health Research and Development (WIHRD) Uterine artery embolisation for fibroids
2003 HAYES, Inc. Endometrial cryoablation
2003 HAYES, Inc. Uterine artery embolization for treatment of fibroids
2003 National Institute for Health and Care Excellence (NICE) Magnetic resonance (MR) image-guided percutaneous laser ablation of uterine fibroids. NICE interventional procedures guidance 30
2002 Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Uterine artery embolization for the treatment of fibroids
2002 Blue Cross Blue Shield Association (BCBS) Uterine artery embolization for treatment of symptomatic uterine fibroids
2002 Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Embolization of uterine fibroids - Early Warning on New Health Technology]
2001 Agency for Healthcare Research and Quality (AHRQ) Management of uterine fibroids - Volume 1. Evidence report; Volume 2. Tables and bibliography
2001 ECRI Uterine fibroid embolization for the treatment of fibroids
1995 The Swedish Council on Health Technology Assessment (SBU) Hysterectomy - Ratings of appropriateness